Estrogen Receptor alpha (Ser106) Polyclonal Antibody, Biotin Conjugated

Applications

ELISA
IHC-P
IHC-F

Reactivity

Human
Rat

Predicted Reactivity

Mouse
Cow
Pig
Horse

Overview
Catalog #	bs-14643R-Biotin
Product Name	Estrogen Receptor alpha (Ser106) Polyclonal Antibody, Biotin Conjugated
Applications	ELISA, IHC-P, IHC-F
Reactivity	Human, Rat
Predicted Reactivity	Mouse, Cow, Pig, Horse
Specifications
Conjugation	Biotin
Host	Rabbit
Source	KLH conjugated Synthesised phosphopeptide derived from human ER alpha around the phosphorylation site of Ser106
Modification Site	Ser106
Clonality	Polyclonal
Isotype	IgG
Concentration	1ug/ul
Purification	Purified by Protein A.
Storage Buffer	Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Storage Condition	Store at -20°C for 12 months.
Target
Gene ID	2099
Swiss Prot	P03372
Subcellular location	Cytoplasm, Nucleus, Cell membrane
Synonyms	Estrogen Receptor alpha (phospho S106); p-Estrogen Receptor alpha (phospho S106); DKFZp686N23123; ER alpha; ER; ER-alpha; Era; ESR; ESR1; ESR1_HUMAN; ESRA; Estradiol receptor; Estrogen nuclear receptor alpha; Estrogen receptor 1; Estrogen receptor alpha 3,4,5,6,7/822 isoform; Estrogen receptor alpha delta 3,4,5,6,7,8/941 isoform; Estrogen receptor alpha delta 3,4,5,6,7/819 2 isoform; Estrogen receptor alpha delta 4 +49 isoform; Estrogen receptor alpha delta 4,5,6,7/654 isoform; Estrogen receptor alpha delta 4,5,6,7,8*/901 isoform; Estrogen receptor; NR3A1; Nuclear receptor subfamily 3 group A member 1.
Background	This gene encodes an estrogen receptor, a ligand-activated transcription factor composed of several domains important for hormone binding, DNA binding, and activation of transcription. The protein localizes to the nucleus where it may form a homodimer or a heterodimer with estrogen receptor 2. Estrogen and its receptors are essential for sexual development and reproductive function, but also play a role in other tissues such as bone. Estrogen receptors are also involved in pathological processes including breast cancer, endometrial cancer, and osteoporosis. Alternative splicing results in several transcript variants, which differ in their 5' UTRs and use different promoters. [provided by RefSeq, Jul 2008]
Application Dilution
ELISA	1:500-1000
IHC-P	1:200-400
IHC-F	1:100-500

Search our catalog of hundreds of thousands of products